Interview with the CFO and COO: Provectus Biopharmaceuticals, Inc. (PVCT)

Healthcare >> CEO Interviews >> November 25, 2014

Peter R. Culpepper, CPA, MBA, is Chief Financial Officer and Chief Operating Officer of Provectus Biopharmaceuticals, Inc. Mr. Culpepper has spent 20 years in the financial field working for a wide range of companies and industries in the U.S. and abroad, especially high-growth startups. His experience with for-profit companies ranges from private startups to publicly traded global conglomerates. He also has worked with large nonprofits and a national CPA accounting firm. He led the national operating unit of a $1 billion publicly traded telecommunications company, as well as numerous operating units in Eastern Europe for a global telecommunications company. He handled the capital reporting process for a $5 billion global construction project and the formation of systems for a division that grew $150 million in revenue in two years. Previous employers include Neptec, Inc., a privately held optical networking component manufacturer; Metromedia Companies; and PageNet, the largest wireless messaging company in the world. Mr. Culpepper holds a Master of Business Administration in finance from the University of Maryland. He earned an AAS in accounting from the Northern Virginia Community College — Annandale, Virginia. He earned a bachelor's degree in philosophy from the College of William & Mary. Profile

TWST: Can you give us a brief overview of Provectus’ business?

Mr. Culpepper: I am pleased to be able to do this again because a lot has transpired, in terms of our corporate and

Join for free to read a longer excerpt or purchase this article

Interview with the CFO and COO: Provectus Biopharmaceuticals, Inc. (PVCT)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the CFO and COO: Provectus Biopharmaceuticals, Inc. (PVCT)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS